Wereldhave N.V.
3.3.2026 07:00:00 CET | Globenewswire | Press release
Wereldhave announces refinancing of Revolving Credit Facility
Wereldhave announces refinancing of Revolving Credit Facility
Wereldhave N.V. has successfully refinanced its syndicated Revolving Credit Facility (‘RCF’) with a multi-tranche € 250m syndicated sustainability-linked RCF. The effective term of the facility is five years, with extension options for up to two years, pushing out the maturity to between 2031 and 2033.
The improved terms are very competitive, capitalizing on Wereldhave's strong operational performance and solid balance sheet.
The lenders in the facility are ABN AMRO Bank, ING Bank and Rabobank. ABN AMRO Bank acted as Coordinator and Sustainability Coordinator. ING Bank is the Facility Agent.
Freshfields advised Wereldhave on the transaction and Hogan Lovells advised the lenders.
As a result, the weighted average term of Wereldhave’s debt increases to 4.3 years (31 December 2025: 3.6 years).
Dennis de Vreede, CFO at Wereldhave comments: “This refinancing underscores the strong confidence our banking partners have in Wereldhave and provides us with the flexibility to continue executing our strategic ambitions. It further reduces our cost of capital and increases our average debt maturities. With this new facility, we strengthen our financial position and continue to create sustainable value for all our stakeholders.”
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom